好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Adding Memantine to Stable Cholinesterase Inhibitor Therapy in Patients with Moderate to Severe Alzheimer’s Disease is Associated with Improvement in Various Neuropsychiatric Symptoms: A Pooled Analysis
Aging, Dementia, and Behavioral Neurology
(-)
106
Authors/Disclosures
Gustavo Alva, MD
PRESENTER 		Dr. Alva has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Alva has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for neurocrine. The institution of Dr. Alva has received research support from Neurocrine.
No disclosure on file
Suzanne Hendrix, PhD (Pentara) Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara.
Vojislav Pejovic, PhD (PMCG) No disclosure on file
Victor Otcheretko No disclosure on file